Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

This study is currently recruiting participants.
Verified November 2013 by University of Nebraska
Sponsor:
Collaborator:
Philips Medical Systems
Information provided by (Responsible Party):
Shahid Hussain, MD, University of Nebraska
ClinicalTrials.gov Identifier:
NCT01007357
First received: October 28, 2009
Last updated: November 21, 2013
Last verified: November 2013
  Purpose

This project will facilitate the optimization of body MR imaging at 3 Tesla.


Condition Intervention
Diffuse and Focal Abnormalities of the Liver and Pancreas
Device: Body MR imaging

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

Further study details as provided by University of Nebraska:

Primary Outcome Measures:
  • to optimize body MR imaging sequences [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: December 2009
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Body MRI healthy volunteers
Body MRI to optimize sequences in healthy individuals and in disorder subjects
Device: Body MR imaging
Body MR imaging will be performed to optimize sequences
Other Name: Body MR imaging performed to optimize sequences

Detailed Description:

This project is meant to improve the image quality of multiple sequences at 3.0T applied to the abdominal and pelvic regions.

  Eligibility

Ages Eligible for Study:   19 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects between ages of 19 and 65
  • Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
  • Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)

Exclusion Criteria:

  • Inability to provide informed consent
  • A medical or contraindications that will prevent subjects from having a MRI
  • Subjects with severe renal dysfunction or patients on dialysis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01007357

Contacts
Contact: Shahid Hussain, MD 402-559-1010 smhussain@unmc.edu

Locations
United States, Nebraska
University of Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68198-1045
Contact: Shahid Hussain, MD    402-559-1010    smhussain@unmc.edu   
University of Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68198
Contact: Shahid Hussain, MD    402-559-1010    smhussan@unmc.edu   
Contact: Marie Witthoft    402-559-4828    mwitthof@unmc.edu   
Sponsors and Collaborators
University of Nebraska
Philips Medical Systems
Investigators
Principal Investigator: Shahid Hussain, MD University of Nebraska
  More Information

No publications provided

Responsible Party: Shahid Hussain, MD, Principal Investigator, University of Nebraska
ClinicalTrials.gov Identifier: NCT01007357     History of Changes
Other Study ID Numbers: 290-09
Study First Received: October 28, 2009
Last Updated: November 21, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Congenital Abnormalities

ClinicalTrials.gov processed this record on April 14, 2014